Cardiovascular Diseases

Sublingual Edaravone Dexborneol Effective for Acute Ischemic Stroke

A double-blind, placebo-controlled, multicenter, parallel-group, phase 3 randomized clinical trial in China revealed that sublingual edaravone dexborneol improved functional outcome at 90 days compared to placebo in patients with acute ischemic stroke (AIS). Within 48 hours of diagnosis, 914 AIS patients (median age, 64.0 [56.0-70.0] years; male 66.5%) were randomly allocated to the edaravone dexborneol (49.2%; edaravone 30 mg; dexborneol 6 mg) or placebo (50.8%; dexborneol 60 μg to simulate the cool taste) group twice daily for 14 days from June 28, 2021, to August 10, 2022, with 90-day follow-up. There was a significantly higher proportion of patients with good functional outcomes at day 90 post randomization in the edaravone dexborneol group compared to the placebo group (64.4% vs 54.7%; net difference, 9.7%; odds ratio, 1.50; P = .003). Adverse events were similar between the 2 groups (89.8% vs 90.1%). The findings have major potential practice implications consider its fast-acting, low cost and convenience, even in unconscious, disabled, or dysphagic patients. Both active ingredients are neuroprotectants with synergistic antioxidant and anti-inflammatory effects. Maximizing access to reperfusion treatment is at the forefront of modern AIS services (time is brain). Source: https://jamanetwork.com

hyangiu

Recent Posts

4:3 Intermittent Fasting Outperforms Daily Caloric Restriction for Weight Loss

A U.S. randomized clinical trial found that 4:3 intermittent fasting (IMF) led to slightly greater…

2 days ago

Comparative CVD Efficacy of Newer Glucose-Lowering Drugs in Elderly T2D Patients

A Danish nationwide cohort study provided real world evidence that both glucagon-like peptide 1 receptor…

1 week ago

Efficacy of Non-Surgical and Non-Interventional Treatments in Low Back Pain

A systematic review and meta-analysis of placebo-controlled randomized trials showed that there is moderate certainty…

2 weeks ago

Statin Use Linked to Lower Risks of HCC and Liver Disease Progression

A US cohort study indicated that statin use may reduce the risks of hepatocellular carcinoma…

2 weeks ago

Clinical Significance of Carotid Artery Plaque with Age and Sex

A US cohort study suggests that carotid artery plaque (CAP) becomes very common with increasing…

3 weeks ago

Substituting Butter with Plant-Based Oils May Improve Survival

A prospective US population-based cohort study suggested that higher intake of butter was associated with…

4 weeks ago

This website uses cookies.